Brace Pharma has 2 portfolio companies on record at Recent Funding. Its most recent investment on record is HotSpot Therapeutics's $65M Series B+ round in May 2020, alongside Tekla Capital Management, SR One, Solasta Ventures and 3 others. By category, its portfolio leans toward Health and bio (2) and Legal and compliance (1).

What Brace Pharma invests in

• Health and bio · 2 · 100%
• Legal and compliance · 1 · 50%
• Data and analytics · 1 · 50%
• Cybersecurity · 1 · 50%

How Brace Pharma invests

Share is of the 1 round on Recent Funding that name Brace Pharma. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Brace Pharma portfolio companies

• HHotSpot Therapeutics$65MSeries B+ · May 2020
• FF2Gbacker

Most frequent co-investors

• MMRL Ventures Fund1 shared round · last May 21, 2020
• AAtlas Venture1 shared round · last May 21, 2020
• SSofinnova Partners1 shared round · last May 21, 2020
• TTekla Capital Management1 shared round · last May 21, 2020
• SSR One1 shared round · last May 21, 2020
• SSolasta Ventures1 shared round · last May 21, 2020

Similar investors

• CCalm/Storm VC2 companies · 2 deals in 12 mo
• GGoHub Ventures2 companies · 2 deals in 12 mo
• HHuatai Zijin Investment2 companies · 2 deals in 12 mo
• IIIMA Ventures2 companies · 2 deals in 12 mo
• SSeventure Partners2 companies · 2 deals in 12 mo
• SSound Bioventures2 companies · 2 deals in 12 mo

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Brace Pharma, which is a subset of its real portfolio. API: /api/v1/investors/brace-pharma (get a free API key). More: the most active VC firms and new venture capital funds.